Beth Zelnick Kaufman - 12 Dec 2024 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role: Chief Legal Officer
Signature: /s/ Beth Zelnick Kaufman
Issuer symbol: CRMD
Transactions as of: 12 Dec 2024
Net transactions value: -$53,006
Form type: 4
Filing time: 16 Dec 2024, 16:15:33 UTC
Previous filing: 14 Dec 2023
Next filing: 18 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRMD	Common Stock	Options Exercise		+12,500	+25%		62,500	12 Dec 2024	Direct	F1
transaction	CRMD	Common Stock	Tax liability	$53,006	-6,044	-9.7%	$8.77	56,456	12 Dec 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRMD	Restricted Stock Units	Options Exercise	$0	-12,500	-25%	$0.000000	37,500	12 Dec 2024	Common Stock	12,500		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	These Restricted Stock Units were granted on 12/12/2023 and vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.